Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
FBO DAILY - FEDBIZOPPS ISSUE OF MAY 19, 2016 FBO #5291
SOLICITATION NOTICE

68 -- 2 kg of ML246 (Metarrestin)

Notice Date
5/17/2016
 
Notice Type
Combined Synopsis/Solicitation
 
NAICS
325412 — Pharmaceutical Preparation Manufacturing
 
Contracting Office
Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse, Station Support/Simplified Acquisitions, 31 Center Drive, Room 1B59, Bethesda, Maryland, 20892, United States
 
ZIP Code
20892
 
Solicitation Number
HHS-NIH-NIDA-(SSSA)-16-357
 
Archive Date
6/11/2016
 
Point of Contact
Andriani Buck, Phone: 3014021677
 
E-Mail Address
andriani.buck@nih.gov
(andriani.buck@nih.gov)
 
Small Business Set-Aside
N/A
 
Description
COMBINED SYNOPSIS / SOLICITATION Title: Acquisition of 2 kg of ML246 (Metarrestin) This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued. The solicitation number is HHS-NIH-NIDA-(SSSA)-16-357 and the solicitation is issued as a request for request for quote (RFQ). This acquisition is for a commercial item or service and is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13-Simplified Acquisition Procedures; FAR Subpart 13.5-Test Program for Certain Commercial Items; and FAR Part 12-Acquisition of Commercial Items, and is not expected to exceed the simplified acquisition threshold. The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2005-87, dated April 6, 2016. This acquisition is unrestricted. The associated NAICS code is 325412 and the small business size standard is 1,250 employees. The purpose of this requirement is to acquire 2 kg of ML246. Background The National Institutes of Health (NIH) is the nation's leading medical research agency and the primary Federal agency whose mission is to seek fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to enhance health, lengthen life, and reduce illness and disability, conducting, supporting and making medical discoveries that improve people's health and save lives. The National Center for Advancing Translational Sciences (NCATS) is a part of the National Institutes of Health (NIH), which mission it is to catalyze the generation of innovative methods and technologies that will enhance the development, testing and implementation of diagnostics and therapeutics across a wide range of human diseases and conditions. The NCATS Chemical Genomics Center (NCGC) is tasked with identifying and developing novel small molecule leads against a wide spectrum of human disease targets, which it accomplishes by screening thousands of small molecules in collaboration with both intra-and extramural researchers. In pursuit of this goal, the Center has a strong internal transdisciplinary team of scientists who continually discover novel small molecules for application against a wide range of human diseases. As such, NCATS is in need of 2 kg of ML246 for follow up for a drug discovery project. Scope of Work Contractor Requirements (Scope of Work) 1.The Contractor must be able to synthesize and provide the NCATS DPI with 2 kg of ML246 (metarrestin) (CAS 1443414-10-5, molecular formula C31H30N40, molecular weight 474.5961) that has been produced using good manufacturing practices (GMP) 2.The small molecules must be guaranteed to have a purity of >99% by HPLC (High Performance Liquid Chromatography), NMR (Nuclear Magnetic Resonance) and mass spectrometry Period of Performance The contractor must provide for shipping and handling to send ML246to NCATS within 8-12 weeks on or about August 1, 2016. Place of Performance Vendor is responsible for delivering ML246. They are to ship the compound to Mr. Ajit Jadhav C/O Paul Shinn 9800 Medical Center Drive, Rockville MD 20850. Type of Contract Contemplated Firm fixed price Evaluation of Quotations The Government will award a contract resulting from this solicitation to the responsible offeror whose quote conforming to the solicitation is the lowest priced technically acceptable offer. Applicable Clauses FAR clause 52.212-1, Instructions to Offerors - Commercial Items, applies to this acquisition. Offerors must include a completed copy of the provision at FAR clause 52.212-3, Offeror Representations and Certifications - Commercial Items, with its offer. A statement that the FAR clause at 52.212-4, Contract Terms and Conditions - Commercial Items, applies to this acquisition and a statement regarding any addenda to the clause. If an addendum applies, include the addenda language. A statement that the FAR clause at 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders-Commercial Items, applies to this acquisition. The Defense Priorities and Allocations System (DPAS) are not applicable to this requirement. Responses to this solicitation must include clear and convincing evidence of the offeror's capability of fulfilling the requirement as it relates to the technical evaluation criteria. The price quote shall include: list price, shipping and handling costs, delivery days after contract award, delivery terms, F.O.B. Point (Destination or Origin), and any other information or factors that may be considered in the award decision. A redacted invoice for a requirement of similar size and scope should be provided to assist in a price reasonableness determination. In addition the Dun & Bradstreet Number (DUNS), the Taxpayer Identification Number (TIN), and the certification of business size must be included in the response. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov. All responses must be received by May 27, 2016, 8:00 am EST and must reference number HHS-NIH-NIDA-(SSSA)-16-243. Responses may be submitted electronically to andriani.buck@nih.gov or by U.S. mail to the National Institute of Drug Abuse (NIDA), Station Support / Simplified Acquisition Branch (SS/SA), 31 Center Drive, Building 31, Room 1B59, Bethesda, Maryland 20892-2080, Attention: Andriani Buck. Fax responses will not be accepted. Contact Andriani Buck at andriani.buck@nih.gov for information regarding the solicitation.
 
Web Link
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/NIDA-2/HHS-NIH-NIDA-(SSSA)-16-357 /listing.html)
 
Place of Performance
Address: National Institutes of Health, 9800 Medical Center Drive, Rockville, Maryland, 20850, United States
Zip Code: 20850
 
Record
SN04119297-W 20160519/160517234645-602feca5f2335a424bf34994fd8a837e (fbodaily.com)
 
Source
FedBizOpps Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  Jenny in Wanderland!  © 1994-2024, Loren Data Corp.